These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 28217916)

  • 1. Effects of allogeneic mesenchymal stem cell transplantation in the treatment of liver cirrhosis caused by autoimmune diseases.
    Liang J; Zhang H; Zhao C; Wang D; Ma X; Zhao S; Wang S; Niu L; Sun L
    Int J Rheum Dis; 2017 Sep; 20(9):1219-1226. PubMed ID: 28217916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis.
    Mohamadnejad M; Alimoghaddam K; Bagheri M; Ashrafi M; Abdollahzadeh L; Akhlaghpoor S; Bashtar M; Ghavamzadeh A; Malekzadeh R
    Liver Int; 2013 Nov; 33(10):1490-6. PubMed ID: 23763455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy.
    Gu F; Wang D; Zhang H; Feng X; Gilkeson GS; Shi S; Sun L
    Clin Rheumatol; 2014 Nov; 33(11):1611-9. PubMed ID: 25119864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study.
    Wang D; Li J; Zhang Y; Zhang M; Chen J; Li X; Hu X; Jiang S; Shi S; Sun L
    Arthritis Res Ther; 2014 Mar; 16(2):R79. PubMed ID: 24661633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus.
    Sun L; Wang D; Liang J; Zhang H; Feng X; Wang H; Hua B; Liu B; Ye S; Hu X; Xu W; Zeng X; Hou Y; Gilkeson GS; Silver RM; Lu L; Shi S
    Arthritis Rheum; 2010 Aug; 62(8):2467-75. PubMed ID: 20506343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience.
    Wang D; Zhang H; Liang J; Li X; Feng X; Wang H; Hua B; Liu B; Lu L; Gilkeson GS; Silver RM; Chen W; Shi S; Sun L
    Cell Transplant; 2013; 22(12):2267-77. PubMed ID: 24388428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients.
    Zhang Z; Lin H; Shi M; Xu R; Fu J; Lv J; Chen L; Lv S; Li Y; Yu S; Geng H; Jin L; Lau GK; Wang FS
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():112-20. PubMed ID: 22320928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study about immunomodulatory effect and efficacy and prognosis of human umbilical cord mesenchymal stem cells in patients with chronic hepatitis B-induced decompensated liver cirrhosis.
    Fang X; Liu L; Dong J; Zhang J; Song H; Song Y; Huang Y; Cui X; Lin J; Chen C; Liu B; Chen Z; Pan J; Chen X
    J Gastroenterol Hepatol; 2018 Apr; 33(4):774-780. PubMed ID: 29293276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow-derived mesenchymal stem cell therapy for decompensated liver cirrhosis: a meta-analysis.
    Pan XN; Zheng LQ; Lai XH
    World J Gastroenterol; 2014 Oct; 20(38):14051-7. PubMed ID: 25320545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis.
    Mohamadnejad M; Alimoghaddam K; Mohyeddin-Bonab M; Bagheri M; Bashtar M; Ghanaati H; Baharvand H; Ghavamzadeh A; Malekzadeh R
    Arch Iran Med; 2007 Oct; 10(4):459-66. PubMed ID: 17903050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous mobilized peripheral blood CD34(+) cell infusion in non-viral decompensated liver cirrhosis.
    Sharma M; Rao PN; Sasikala M; Kuncharam MR; Reddy C; Gokak V; Raju B; Singh JR; Nag P; Nageshwar Reddy D
    World J Gastroenterol; 2015 Jun; 21(23):7264-71. PubMed ID: 26109814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic bone marrow mesenchymal stem cell transplantation in patients with UDCA-resistant primary biliary cirrhosis.
    Wang L; Han Q; Chen H; Wang K; Shan GL; Kong F; Yang YJ; Li YZ; Zhang X; Dong F; Wang Q; Xu D; Hu ZJ; Wang SH; Keating A; Bi YL; Zhang FC; Zhao RC
    Stem Cells Dev; 2014 Oct; 23(20):2482-9. PubMed ID: 24835895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prospective controlled trial of safety of human umbilical cord derived-mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis].
    Lin H; Zhang Z; Shi M; Xu RN; Fu JL; Geng H; Li YY; Yu SJ; Chen LM; Lv S; Wang FS
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jul; 20(7):487-91. PubMed ID: 23044231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of autologous mesenchymal stem cell transplantation in patients with liver cirrhosis.
    Kantarcıoğlu M; Demirci H; Avcu F; Karslıoğlu Y; Babayiğit MA; Karaman B; Öztürk K; Gürel H; Akdoğan Kayhan M; Kaçar S; Kubar A; Öksüzoğlu G; Ural AU; Bağcı S
    Turk J Gastroenterol; 2015 May; 26(3):244-50. PubMed ID: 26006200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis.
    Wang L; Li J; Liu H; Li Y; Fu J; Sun Y; Xu R; Lin H; Wang S; Lv S; Chen L; Zou Z; Li B; Shi M; Zhang Z; Wang FS
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():85-92. PubMed ID: 23855301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus Erythematosus.
    Wang D; Zhang H; Liang J; Wang H; Hua B; Feng X; Gilkeson GS; Farge D; Shi S; Sun L
    Stem Cell Reports; 2018 Mar; 10(3):933-941. PubMed ID: 29478901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potentials of umbilical cord-derived mesenchymal stromal cells for ischemic-type biliary lesions following liver transplantation.
    Zhang YC; Liu W; Fu BS; Wang GY; Li HB; Yi HM; Jiang N; Wang G; Zhang J; Yi SH; Li H; Zhang Q; Yang Y; Chen GH
    Cytotherapy; 2017 Feb; 19(2):194-199. PubMed ID: 27964826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
    Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A
    Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety of umbilical cord mesenchymal stem cells transplantation for systemic lupus erythematosus: a 6-year follow-up study.
    Wang D; Niu L; Feng X; Yuan X; Zhao S; Zhang H; Liang J; Zhao C; Wang H; Hua B; Sun L
    Clin Exp Med; 2017 Aug; 17(3):333-340. PubMed ID: 27270729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy and safety of umbilical cord mesenchymal stem cell transplantation for liver cirrhosis in Chinese population: A meta-analysis.
    Sang W; Lv B; Li K; Lu Y
    Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):193-204. PubMed ID: 29223366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.